NewEdge Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $471K | Buy |
17,755
+15,418
| +660% | +$409K | ﹤0.01% | 1732 |
|
2025
Q1 | $56.4K | Buy |
2,337
+269
| +13% | +$6.5K | ﹤0.01% | 2515 |
|
2024
Q4 | $83.2K | Buy |
2,068
+1,076
| +108% | +$43.3K | ﹤0.01% | 2343 |
|
2024
Q3 | $62.8K | Sell |
992
-10,532
| -91% | -$667K | ﹤0.01% | 2360 |
|
2024
Q2 | $611K | Sell |
11,524
-2,093
| -15% | -$111K | ﹤0.01% | 1301 |
|
2024
Q1 | $1.12M | Buy |
13,617
+13,023
| +2,192% | +$1.07M | 0.01% | 951 |
|
2023
Q4 | $11.1K | Buy |
+594
| New | +$11.1K | ﹤0.01% | 2800 |
|